Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study
- PMID: 15448093
- DOI: 10.2337/diabetes.53.10.2623
Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study
Abstract
A limited number of studies have reported associations of markers of liver injury, including elevated concentrations of aspartate aminotransferase (AST) and alanine aminotransferase (ALT), with prospective risk of type 2 diabetes. However, only one study has adjusted for a detailed measure of insulin sensitivity (insulin sensitivity index [S(i)]), which is important given associations of obesity and S(i) with nonalcoholic fatty liver disease (NAFLD). Our objective was to investigate the associations of elevated AST and ALT with incident type 2 diabetes among 906 participants in the Insulin Resistance Atherosclerosis Study who were nondiabetic at baseline. S(i) and acute insulin response (AIR) were measured directly from the frequently sampled intravenous glucose tolerance test among black, Hispanic, and non-Hispanic white participants aged 40-69 years. After 5.2 years, 148 individuals had developed type 2 diabetes. Baseline AST and ALT were positively correlated with fasting insulin (r = 0.22 and r = 0.35, respectively), waist circumference (r = 0.18 and r = 0.34), and fasting glucose (r = 0.13 and r = 0.29) and inversely with S(i) (r = -0.18 and r = -0.30; all P < 0.0001). In separate logistic regression models adjusting for age, sex, ethnicity, clinical center, and alcohol consumption, participants in the highest quartiles (Q4) of AST and ALT were at significantly increased risk of incident type 2 diabetes compared with those in the lowest three quartiles (Q1-Q3): AST: odds ratio (OR) 1.73 (95% CI 1.17-2.57); ALT: OR 2.32 (1.36-3.75). After further adjustment for smoking, waist circumference, triglyceride, HDL, impaired glucose tolerance, S(i), and AIR, both AST and ALT remained significantly associated with incident type 2 diabetes: AST, Q4 vs. Q1-Q3: OR 1.98 (1.23-3.17); ALT, Q4 vs. Q1-Q3: OR 2.00 (1.22-3.28). There were no interactions of sex, ethnicity, obesity, impaired glucose tolerance, or S(i) with AST or ALT in the prediction of type 2 diabetes. When entered into the same model with adjustment for demographic variables, both C-reactive protein and ALT independently predicted type 2 diabetes. In addition, AST and ALT were positively associated with incident type 2 diabetes after excluding former and moderate to heavy drinkers. In conclusion, AST and ALT independently predict type 2 diabetes. Baseline elevations of these markers may reflect NAFLD or related pathologies.
Similar articles
-
Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study.Diabetes. 2005 Nov;54(11):3140-7. doi: 10.2337/diabetes.54.11.3140. Diabetes. 2005. PMID: 16249437
-
High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes.Diabetes. 2002 Jun;51(6):1889-95. doi: 10.2337/diabetes.51.6.1889. Diabetes. 2002. PMID: 12031978
-
Associations of White Blood Cell Count,Alanine Aminotransferase,and Aspartate Aminotransferase in the First Trimester withGestational Diabetes Mellitus.Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016 Jun 10;38(3):283-7. doi: 10.3881/j.issn.1000-503X.2016.03.007. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016. PMID: 27469912
-
AST to ALT ratio and arterial stiffness in non-fatty liver Japanese population:a secondary analysis based on a cross-sectional study.Lipids Health Dis. 2018 Dec 3;17(1):275. doi: 10.1186/s12944-018-0920-4. Lipids Health Dis. 2018. PMID: 30509277 Free PMC article. Review.
-
Liver chemistries in glycogenic hepatopathy associated with type 1 diabetes mellitus: A systematic review and pooled analysis.Liver Int. 2021 Jul;41(7):1545-1555. doi: 10.1111/liv.14827. Epub 2021 Feb 28. Liver Int. 2021. PMID: 33595181
Cited by
-
Differences in the risk of fatty liver for onset of impaired fasting glucose according to baseline plasma glucose levels.J Gastroenterol. 2017 Feb;52(2):237-244. doi: 10.1007/s00535-016-1234-9. Epub 2016 Jun 24. J Gastroenterol. 2017. PMID: 27342127
-
Cardiovascular disease in diabetes.Diabetes Care. 2010 Apr;33(4):e49-54. doi: 10.2337/dc10-zb04. Diabetes Care. 2010. PMID: 20351221 Free PMC article. No abstract available.
-
Hepatic fat and glucose tolerance in women with recent gestational diabetes.BMJ Open Diabetes Res Care. 2018 Sep 8;6(1):e000549. doi: 10.1136/bmjdrc-2018-000549. eCollection 2018. BMJ Open Diabetes Res Care. 2018. PMID: 30233804 Free PMC article.
-
Ramipril significantly attenuates the development of non-alcoholic steatohepatitis in hyperlipidaemic rabbits.Am J Cardiovasc Dis. 2019 Apr 15;9(2):8-17. eCollection 2019. Am J Cardiovasc Dis. 2019. PMID: 31131153 Free PMC article.
-
Increasing prevalence of diabetes mellitus in association with fatty liver in a Japanese population.J Gastroenterol. 2014 Oct;49(10):1406-13. doi: 10.1007/s00535-013-0902-2. Epub 2013 Oct 31. J Gastroenterol. 2014. PMID: 24170184
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials